Adial Pharmaceuticals's total assets for Q1 2024 were $6.68M, an increase of 41.12% from the previous quarter. ADIL total liabilities were $562.73K for the fiscal quarter, a -13.83% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.